Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Arcturus Therapeutics Holdings Inc
About ARCT
Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.
Find out what a historical investment in Arcturus Therapeutics Holdings Inc would be worth today using our ARCT stock calculator.
Market Capitalisation
$190.15M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
427.99K
High today
$6.95
Low today
$6.70
Open price
$6.70
52-week high
$24.17
52-week low
$5.85
Ready to start your investing journey with Stake?
Open an accountHow do I buy ARCT shares in Australia?
Buying ARCT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Arcturus Therapeutics Holdings Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ARCT
What is the ticker symbol of Arcturus Therapeutics Holdings Inc?
The ticker symbol for Arcturus Therapeutics Holdings Inc is ARCT.
How much is one share of ARCT?
One share of ARCT is valued at $6.84 as of 20 May 2026.
What is the market capitalisation of Arcturus Therapeutics Holdings Inc ARCT?
As of 20 May 2026 Arcturus Therapeutics Holdings Inc has a market cap of $190.15M.
What is the 52-week high for Arcturus Therapeutics Holdings Inc stock?
The Arcturus Therapeutics Holdings Inc 52-week high stock price is $24.17.
What is the 52-week low for Arcturus Therapeutics Holdings Inc stock?
The Arcturus Therapeutics Holdings Inc 52-week low stock price is $5.85.
Can I buy ARCT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ARCT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ARCT on Stake
- Buy ARCT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ARCT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ARCT related stocks